Globus Medical, Inc.
GMED
Κατάταξη σε μετοχές
#1987
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Τιμή μετοχής
$79.05
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$10.61B
Αλλαγή (1 ημέρα)
4.29%
Αλλαγή (1 έτος)
26.02%
Χώρα
US
Εμπόριο Globus Medical, Inc. (GMED)
Κατηγορία
Healthcare
Κέρδη για την Globus Medical, Inc. (GMED)
Κέρδη τον Jun 2026 TTM: $664.95M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Globus Medical, Inc., τα τρέχοντα κέρδη της εταιρείας είναι $664.95M. Το 2023, η εταιρεία παρουσίασε κέρδη $165.39M, μείωση σε σύγκριση με των κερδών του 2022 που ήταν $243.02M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Globus Medical, Inc. από 2009 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $664.95M | 450.81% |
| 2024 | $120.72M | -27.01% |
| 2023 | $165.39M | -31.94% |
| 2022 | $243.02M | 34.71% |
| 2021 | $180.41M | 43.30% |
| 2020 | $125.90M | -33.72% |
| 2019 | $189.95M | 0.71% |
| 2018 | $188.61M | 10.99% |
| 2017 | $169.93M | 8.04% |
| 2016 | $157.28M | -8.98% |
| 2015 | $172.81M | 24.64% |
| 2014 | $138.64M | 35.92% |
| 2013 | $102.00M | -11.04% |
| 2012 | $114.65M | 18.26% |
| 2011 | $96.95M | 10.50% |
| 2010 | $87.74M | 7.29% |
| 2009 | $81.78M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $7.51B | 1,029.56% |
US
|
|
| $5.56B | 736.60% |
IE
|
|
| $5.15B | 674.19% |
US
|
|
| $3.86B | 480.65% |
US
|
|
| - | - |
DE
|
